Vestmark Advisory Solutions, Inc.
Position in CGTX — Cognition Therapeutics Inc
CIK 1736982
Wakefield, MA
Position in CGTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,546
+$3,916 QoQ
Shares Held
10,040
0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 66 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vestmark Advisory Solutions, Inc. holds $73,342,513 across 34 Biotechnology names. CGTX ranks #33 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
242,266 | $13,213,187 | |
| 2 | NTLA |
Intellia Therapeutics, Inc.
|
532,817 | $9,015,263 | |
| 3 | TWST |
Twist Bioscience Corp
|
85,142 | $8,759,408 | |
| 4 | BEAM |
Beam Therapeutics Inc.
|
164,164 | $5,634,108 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,762 | $3,855,617 | |
| 6 | TECH |
BIO-TECHNE Corp
|
44,928 | $3,174,163 | |
| 7 | RXRX |
Recursion Pharmaceuticals, Inc.
|
708,858 | $2,601,507 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8,217 | $2,473,562 |
All Filings in CGTX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,546 | 10,040 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $7,630 | 10,040 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||